Genome-wide DNA Methylation Analysis Reveals GABBR2 as a Novel Epigenetic Target for EGFR 19 Deletion Lung Adenocarcinoma with Induction Erlotinib …
X Niu, F Liu, Y Zhou, Z Zhou, D Zhou, T Wang, Z Li… - Clinical Cancer …, 2017 - AACR
Purpose: The past decade has witnessed the rapid development of personalized targeted
therapies in lung cancer. It is still unclear whether epigenetic changes are involved in the …
therapies in lung cancer. It is still unclear whether epigenetic changes are involved in the …
Genome-wide DNA Methylation Analysis Reveals GABBR2 as a Novel Epigenetic Target for EGFR 19 Deletion Lung Adenocarcinoma with Induction Erlotinib …
X Niu, F Liu, Y Zhou, Z Zhou, D Zhou… - … : an official journal …, 2017 - pubmed.ncbi.nlm.nih.gov
Purpose: The past decade has witnessed the rapid development of personalized targeted
therapies in lung cancer. It is still unclear whether epigenetic changes are involved in the …
therapies in lung cancer. It is still unclear whether epigenetic changes are involved in the …
[引用][C] Genome-wide DNA Methylation Analysis Reveals GABBR2 as a Novel Epigenetic Target for EGFR 19 Deletion Lung Adenocarcinoma with Induction Erlotinib …
X Niu, F Liu, Y Zhou, Z Zhou, D Zhou, T Wang… - Clinical Cancer …, 2017 - cir.nii.ac.jp
Genome-wide DNA Methylation Analysis Reveals GABBR2 as a Novel Epigenetic Target for
EGFR 19 Deletion Lung Adenocarcinoma with Induction Erlotinib Treatment | CiNii Research …
EGFR 19 Deletion Lung Adenocarcinoma with Induction Erlotinib Treatment | CiNii Research …
[PDF][PDF] Genome-wide DNA Methylation Analysis Reveals GABBR2 as a Novel Epigenetic Target for EGFR 19 Deletion Lung Adenocarcinoma with Induction Erlotinib …
X Niu, F Liu, Y Zhou, Z Zhou, D Zhou, T Wang, Z Li… - 2017 - scholar.archive.org
Purpose: The past decade has witnessed the rapid development of personalized targeted
therapies in lung cancer. It is still unclear whetherepigeneticchangesareinvolvedinth …
therapies in lung cancer. It is still unclear whetherepigeneticchangesareinvolvedinth …
Genome-wide DNA Methylation Analysis Reveals GABBR2 as a Novel Epigenetic Target for EGFR 19 Deletion Lung Adenocarcinoma with Induction Erlotinib …
X Niu, F Liu, Y Zhou, Z Zhou, D Zhou… - … Cancer Research: an …, 2017 - europepmc.org
Purpose: The past decade has witnessed the rapid development of personalized targeted
therapies in lung cancer. It is still unclear whether epigenetic changes are involved in the …
therapies in lung cancer. It is still unclear whether epigenetic changes are involved in the …